Fucoxanthin

DB15462InvestigationalSmall molecule

Fucoxanthin is under investigation in clinical trial NCT03613740 (Effect of Fucoxanthin on the Components of the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion). Fucoxanthin isis a marine carotenoid mainly found... Fucoxanthin is investigated for its anti-inflammatory, antinociceptive and anti-cancer effects.

Formula / weight: C₄₂H₅₈O₆ · 658.92 g/mol (avg)

Resolves to

Compound

UNII06O0TC0VSMCAS3351-86-8ChEBI5186

Structure

InChIKeySJWWTRQNNRNTPU-XJUZQKKNSA-NSMILES

CC(=O)O[C@H]1CC(C)(C)C(=[C@@]=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@@]23O[C@]2(C)C[C@@H](O)CC3(C)C)[C@](C)(O)C1

Targets

P25963NFKBIA

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Fucoxanthin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account